Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
Yun Shin Chun, Milind Javle
Cancer Control (2017) Vol. 24, Iss. 3, pp. 107327481772924-107327481772924
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Downregulation of Fat Mass and Obesity Associated (FTO) Promotes the Progression of Intrahepatic Cholangiocarcinoma
Zhuoxian Rong, Zhi Li, Junju He, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 107
Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma
Liang-Shuo Hu, Xu‐Feng Zhang, Matthew J. Weiss, et al.
Annals of Surgical Oncology (2019) Vol. 26, Iss. 8, pp. 2549-2557
Closed Access | Times Cited: 100
First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”
Alessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100335-100335
Open Access | Times Cited: 80
Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi
Cancer Control (2020) Vol. 27, Iss. 3
Open Access | Times Cited: 76
Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100337-100337
Open Access | Times Cited: 76
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience
Giovanni Brandi, Alessandro Rizzo, Filippo Gustavo Dall’Olio, et al.
International Journal of Hyperthermia (2020) Vol. 37, Iss. 1, pp. 479-485
Open Access | Times Cited: 67
Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western Patients
Jingyu Cao, Jing Hu, Siqin Liu, et al.
JCO Precision Oncology (2020), Iss. 4, pp. 557-569
Open Access | Times Cited: 64
Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience
Meredith C. Mason, Nader N. Massarweh, Ching‐Wei D. Tzeng, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 11, pp. 6725-6735
Closed Access | Times Cited: 43
PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology
Zheng Chen, Mincheng Yu, Jiuliang Yan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
Preoperative prediction of lymph node metastasis in intrahepatic cholangiocarcinoma: an integrative approach combining ultrasound-based radiomics and inflammation-related markers
Yuting Peng, Jin-shu Pang, Peng Lin, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
Ziting Peng, Jianhui Dong, Shuyao Tang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: A case report
Hailing Yu, Tan Deng, Hongbing Liu
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma
Fangda Li, Malalage N. Peiris, Daniel J. Donoghue
Cytokine & Growth Factor Reviews (2019) Vol. 52, pp. 56-67
Open Access | Times Cited: 52
The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
Qiao Ke, Nanping Lin, Manjun Deng, et al.
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0229292-e0229292
Open Access | Times Cited: 39
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns
Mason A. Israel, Natalie Danziger, Kimberly McGregor, et al.
The Oncologist (2021) Vol. 26, Iss. 9, pp. 787-796
Open Access | Times Cited: 33
PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score
Yoon Ah Cho, Hyunwoo Lee, Deok Geun Kim, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4659-4659
Open Access | Times Cited: 32
Preoperative prediction of textbook outcome in intrahepatic cholangiocarcinoma by interpretable machine learning: A multicenter cohort study
Tingfeng Huang, Cong Luo, Luo-Bin Guo, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access
Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma
Grace C. Lee, T. Clark Gamblin, Zhi Ven Fong, et al.
Annals of Surgical Oncology (2019) Vol. 26, Iss. 12, pp. 4091-4099
Open Access | Times Cited: 40
Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in intrahepatic cholangiocarcinoma surgery
Hou‐Chuan Lai, Meei‐Shyuan Lee, Kuen‐Tze Lin, et al.
Medicine (2019) Vol. 98, Iss. 51, pp. e18472-e18472
Open Access | Times Cited: 39
Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma
Qi Lu, Tao Fang
Journal of Clinical Laboratory Analysis (2019) Vol. 34, Iss. 4
Open Access | Times Cited: 37
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
Nicola Personeni, Ana Lleó, Tiziana Pressiani, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3370-3370
Open Access | Times Cited: 36
Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study
Zeyu Zhang, Yufan Zhou, Kuan Hu, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 34
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro
Advances in cancer research (2020), pp. 321-387
Open Access | Times Cited: 34
Lenvatinib Combined With a PD-1 Inhibitor as Effective Therapy for Advanced Intrahepatic Cholangiocarcinoma
Lulu Xie, Jingzheng Huang, Linling Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver?
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100356-100356
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top